about
Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cellsBench-to-bedside review: genetic influences on meningococcal diseaseT-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppressionThe role of complement system in septic shockChanges in immune parameters and their correction in human cases of tick-borne encephalitisInhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytesIntensive care.IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants.Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation.Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection.The era of molecular and other non-culture-based methods in diagnosis of sepsisThe cellular source of interleukin-6 during Listeria infection.Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock.Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsisRole of interleukin-6 in mortality from and physiologic response to sepsisTolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.Comparison of serum and cell-specific cytokines in humansCirculating inflammatory mediators in patients with fever: predicting bloodstream infection.IL-6 in diabetes and cardiovascular complications.Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.Abandon the mouse research ship? Not just yet!Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels.Dysregulation of in vitro cytokine production by monocytes during sepsisAlveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infectionInducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3.Role of the mTOR pathway in LPS-activated monocytes: influence of hypertonic salineEffect of remifentanil on mitochondrial oxygen consumption of cultured human hepatocytes.Management of acute right ventricular failure in the intensive care unitMyristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.Cytokine responses to Staphylococcus aureus bloodstream infection differ between patient cohorts that have different clinical courses of infection.Label-free microcavity biosensors: steps towards personalized medicine.Neonatal sepsis and inflammatory mediators.Severe septic patients with mitochondrial DNA haplogroup JT show higher survival rates: a prospective, multicenter, observational study.Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.Early elevation in random plasma IL-6 after severe injury is associated with development of organ failureThe novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis
P2860
Q24529580-CB6189C3-6ECB-4D21-9134-ED9A27326815Q24798186-D646F707-4BB0-45CC-BBC5-5340828A1E37Q26823892-3667335A-2CF5-425A-A4CB-C696F5A3A167Q27027974-AE112DAB-78DC-4F30-B38A-ED0D7C8655F2Q27478107-F9BB0854-F6FE-460A-A1E4-20D92BA3AEFCQ28574979-1CC21984-FC86-425C-A737-C91692EFE6E7Q30493400-1AA6954B-9D56-452A-97CB-07CC3F33D430Q33239769-B387497F-51A5-4C27-8BDD-CE6B76F513E9Q33353364-B7E86942-F3C3-4D19-A047-15FED5AEEB32Q33356537-F5CD049B-5580-4F83-B8F5-269E2B4F7546Q33494319-6FC955DB-29B8-487B-8D23-04434C93D319Q33574264-C4517888-A04D-4D69-815D-5CCC6D481432Q33591270-B7A062F1-456D-490F-A004-E0E0039C411CQ33600832-3D22CD68-2928-4FF2-A509-37A2D79EFB57Q33721339-39E1AE59-1F54-4CBE-B144-AD5B7303DDD5Q33751383-6CD40FF7-8376-4A47-AB1D-CB563E3C17EFQ33769122-07F67032-F20B-4FBA-BC6B-FF2DDCB3CFB7Q33892692-E23AC548-256B-4F5C-AB19-C97325BA3916Q33999709-497C621E-4204-41F2-A558-3A11E92D1B3BQ33999769-70C66E1C-0DA5-42AE-AA6A-F4A45AC83912Q34025142-FD4ABD08-3C19-4436-886C-CA23C737520CQ34049911-E7D2AF42-5F16-49C2-B574-FC4C5F954C67Q34069683-BB210726-FBC5-42CD-8B03-EEDDC37EB5A9Q34089741-8B690631-51AD-4902-940B-BCDBFACAC9EAQ34211246-87EE6454-8E1E-43FE-88E9-37E9A03FFD2DQ34229306-35480566-C124-4E73-9195-312E772700A6Q34259037-D993E31E-30E7-497A-806C-88562CD05B55Q34283654-10A35A61-D771-4537-A3E7-ED9F3F1CE55FQ34398929-D2E0E5B2-F221-401A-9239-729E1C068D7BQ34424858-A6468DA9-63B7-468A-86CE-00FEFD8E00AAQ34428320-11760103-C412-44E0-A04D-0F201773BC79Q34479233-4C892A7D-89A5-42CA-9EC5-571907B18672Q34518568-F45F5324-23F8-4ACC-9D2D-8CB823DEDA72Q34544064-6CEBA875-0D88-4E10-988D-646561BFE895Q34601506-2C612AB4-7A1E-4B87-9113-4758C0B918A0Q34970523-CA5B638A-117A-4768-93F4-740A629C6D8AQ34998635-4604DDA0-6FE6-45D9-9623-77734F85D5F6Q34999385-54BFCB64-3C76-4980-BAD1-FC3D2C5817A3Q35065087-C726F299-0112-410A-B846-A6F3D0D681C8Q35105870-C30B4C00-3B03-42FE-B7B3-EA36EAD36E9F
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Increased plasma levels of interleukin-6 in sepsis.
@en
type
label
Increased plasma levels of interleukin-6 in sepsis.
@en
prefLabel
Increased plasma levels of interleukin-6 in sepsis.
@en
P2093
P1433
P1476
Increased plasma levels of interleukin-6 in sepsis.
@en
P2093
De Groot ER
Eerenberg-Belmer AJ
Felt-Bersma RJ
Nuijens JH
Strack Van Schijndel RJ
P304
P407
P577
1989-10-01T00:00:00Z